trial · primary record
Atezolizumab
Anatomic Stage IV Breast Cancer AJCC v8
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 28 |
| Primary completion | 2023-09-19 |
| Primary endpoint | Progression-free Survival (PFS) |
| Registry ID | NCT03853707 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:33.918Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03853707
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Atezolizumab · compound